Viaskin Milk 150 mcg + Viaskin Milk 300 mcg + Viaskin Milk 500 mcg + Viaskin Placebo
Phase 1/2Completed 0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Food Allergy
Conditions
Food Allergy
Trial Timeline
Nov 1, 2014 → Dec 22, 2020
NCT ID
NCT02223182About Viaskin Milk 150 mcg + Viaskin Milk 300 mcg + Viaskin Milk 500 mcg + Viaskin Placebo
Viaskin Milk 150 mcg + Viaskin Milk 300 mcg + Viaskin Milk 500 mcg + Viaskin Placebo is a phase 1/2 stage product being developed by DBV Technologies for Food Allergy. The current trial status is completed. This product is registered under clinical trial identifier NCT02223182. Target conditions include Food Allergy.
What happened to similar drugs?
2 of 3 similar drugs in Food Allergy were approved
Approved (2) Terminated (1) Active (0)
Hype Score Breakdown
Clinical
9
Activity
8
Company
9
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02223182 | Phase 1/2 | Completed |
Competing Products
17 competing products in Food Allergy